https://www.testosterone.me/testosterone-therapy-reduces-mortality-risk-among-diabetics-even-when-accounting-for-improvements-in-cardiovascular-risk-factors
For men, Testosterone Replacement Therapy confers some fantastic benefits. While there was a time not so long ago where Bio-Identical Testosterone was thought to have potentially adverse severe risks, recent research continues to provide increasing evidence that Testosterone Treatments are quite safe and provide excellent benefits for men nationwide struggling with Low-T.
While Testosterone was first used in adults for those struggling with low sex drive, erectile dysfunction, and fatigue, the range of patients that are believed to potentially benefit from Testosterone Restoration continues to broaden.
A recent study published by BJU International provides evidence that Testosterone Replacement Therapy is highly beneficial for patients dealing with the effects of Type-2 Diabetes.
Testosterone is increasingly prescribed to men struggling with Type-2 Diabetes because the condition can lead to severe disruption of Testosterone Production. One of the objectives of this study was to differentiate whether the health benefits of Low-T Treatment are associated with a healthier cardiovascular system or some other factor or confluence of factors.
Does Testosterone Benefit Patients with Type-2 Diabetes?
It's been hypothesized that Bio-Identical Testosterone can mitigate mortality risk among males with Type-2 Diabetes. This study provides evidence pointing toward that hypothesis, but it also appears to rule out improved Cardiovascular Health as a contributing factor toward that diminished mortality risk.
This study was conducted by Geoffery Hackett and a team of fellow researchers. The study was performed on behalf of the University Hospitals Birmingham National Health Service Foundation Trust. This study collected data from 857 males diagnosed with Type-2 Diabetes.
These patients were all drawn from participants screened for the BLAST Randomized Control Trial. For this study, normal Testosterone baseline was considered a Free Testosterone of 0.25 nmol/L and Total Testosterone measuring more than 12 nmol/L.
Participants Organized By Testosterone Levels and Form of Treatment
These 857 subjects were split into different groups dependent upon particular variables. Group One was comprised of men diagnosed with Type-2 Diabetes that measured normal Testosterone Levels. Members of Group 2 tested positive for Testosterone Deficiency based off of the stated parameters.
These groups were further subdivided dependent on whether they received Bio-Identical Testosterone for Hypogonadism (Group 2A received no treatment, and Group 2B received Testosterone Therapy).
Those that were diagnosed Testosterone were further delineated into those that continued to take Testosterone and those that discontinued treatment (Group 2B1 stopped therapy, and Group 2B2 continued to receive Testosterone Treatments.)
Testosterone Therapy Diminishes Mortality Risk Among Men with Type-2 Diabetes
After these groups were separated, their information was analyzed concerning mortality risk using advanced Cox Regression Analyses.
Analysis showed that men with healthy Testosterone Levels and those using Bio-Identical Testosterone to bolster Free and Total Testosterone had lower Mortality risk than those that were not prescribed Therapeutic Testosterone. Participants were followed over 3.8 years.
This increase in mortality risk remained significant even when accounting for cholesterol, blood pressure, HbA1c Levels, and BMI. Men that weighed less than 206 pounds and were more than 64.6 years old experienced the most significant benefits about reduced mortality risk.
